For marginal zone lymphoma cells, levels of BCL2 family members were similar to DLBCL, but they were quite sensitive to venetoclax, navitoclax, and MCL1 inhibition, and combination treatments with venetoclax showed cooperation (Figure 2F, Supplementary Figure S2F). The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.